Abstract:Objective: To explore the genetic basis of two fetuses with an osteogenesis imperfecta (OI) phenotype. Methods: Two fetuses diagnosed at the Affiliated Hospital of Weifang Medical College respectively on June 11, 2021 and October 16, 2021 were selected as the study subjects. Clinical data of the fetuses were collected. Amniotic fluid samples of the fetuses and peripheral blood samples of their pedigree members were collected for the extraction of genomic DNA. Whole exome sequencing (WES) and Sanger sequencing were carried out to identify the candidate variants. Minigene splicing reporter analysis was used to validate the variant which may affect the pre-mRNA splicing. Results: For fetus 1, ultrasonography at 17+6 weeks of gestation had revealed shortening of bilateral humerus and femurs by more than two weeks, in addition with multiple fractures and angular deformities of long bones. WES revealed that fetus 1 had harbored a heterozygous c.3949_3950insGGCATGT (p.N1317Rfs*114) variant in exon 49 of the COL1A1 gene (NM_000088.4). Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), it was classified as a pathogenic variant (PVS1+PS2+PM2_Supporting) for disrupting the downstream open reading frame resulting in premature translational termination, being de novo in origin, and lacking records in the population and disease databases.For fetus 2, ultrasonography at 23 weeks of gestation also revealed shortening of bilateral humerus and femurs by one and four weeks, respectively, in addition with bending of bilateral femurs, tibias and fibulas. Fetus 2 had harbored a heterozygous c.1557+3A>G variant in intron 26 of the COL1A2 gene (NM_000089.4). Minigene experiment showed that it has induced skipping of exon 26 from the COL1A2 mRNA transcript, resulting in an in-frame deletion (c.1504_1557del) of the COL1A2 mRNA transcript. The variant was inherited from its father and had been previously reported in a family with OI type 4. It was therefore classified as a pathogenic variant (PS3+PM1+PM2_Supporting+PP3+PP5). Conclusion: The c.3949_3950insGGCATGT (p.N1317Rfs*114) variant in the COL1A1 gene and c.1557+3A>G variant in the COL1A2 gene probably underlay the disease in the two fetuses. Above findings not only have enriched the mutational spectrum of OI, but also shed light on the correlation between its genotype and phenotype and provided a basis for genetic counseling and prenatal diagnosis for the affected pedigrees.

[Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta]

Mutation Analysis of COL1A1 and COL1A2 in Fetuses with Osteogenesis Imperfecta Type II/III

Identification and Molecular Characterization of Two Novel Mutations in COL1A2 in Two Chinese Families with Osteogenesis Imperfecta

A De novo Mutation in the COL1A1 Gene Leading to Severe Osteogenesis Imperfecta: Case Report and Review of the Literature

Two Novel Mutations of COL1A1 in Fetal Genetic Skeletal Dysplasia of Chinese

Co-occurrence of heterozygous mutations in COL1A1 and SERPINF1 in a high-risk pregnancy complicated by osteogenesis imperfecta

Prenatal Cases Reflect the Complexity of the COL1A1/2 Associated Osteogenesis Imperfecta

Confirmation of the Pathogenicity of a Mutation P.g337c in the COL1A2 Gene Associated with Osteogenesis Imperfecta.

A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family

Carrying both COL1A2 and FBN2 gene heterozygous mutations results in a severe skeletal clinical phenotype: an affected family

Genetic Diagnosis of Six Fetuses with Osteogenesis Imperfecta

[Prenatal phenotype and genetic analysis of a fetus with Fibrochondrogenesis 1 due to compound heterozygous variants of COL11A1 gene]

Clinical and genetic analysis in 185 Chinese probands of osteogenesis imperfecta

[A New Mutation in COL1A1 Gene in a Family with Osteogenesis Imperfecta].

Mutation Detection of COL1A1 Gene in a Pedigree with Osteogenesis Imperfecta

A Novel Frameshift Deletion in the COL1A1 Gene Identified in a Chinese Family with Osteogenesis Imperfecta.

Effectiveness of whole exome sequencing analyses in the molecular diagnosis of osteogenesis imperfecta

Genotype-Phenotype Association Analysis Reveals New Pathogenic Factors for Osteogenesis Imperfecta Disease.

Targeted Exome Sequencing Identifies Novel Compound Heterozygous Mutations in P3H1 in a Fetus with Osteogenesis Imperfecta Type VIII.

Mutations in COL1A1 of Type I Collagen Genes in Chinese Patients with Osteogenesis Imperfecta

Application of Next-Generation Sequencing for Molecular Diagnosis in a Large Family with Osteogenesis Imperfecta Type I